Form D · Other Health Care

Amphivena Therapeutics, Inc.

South San Francisco, CA · CIK 0001582186

Offering snapshot reported Dec 19, 2018 · SEC filing

Reported sold
$38.7M
Offering amount: $50M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 10, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 19, 2018Initial$38,694,170No comparison15SEC filing
Jul 26, 2017Initial$7,000,000No comparison2SEC filing
Jun 26, 2017Amendment$19,499,999$5,499,999vs May 4, 20154SEC filing
May 4, 2015Amendment$14,000,000$9,800,000vs Jul 26, 20134SEC filing
Jul 26, 2013Initial$4,200,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-328368

Source: Form D, filed Dec 19, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Vinay Bhaskar Director
Luke Evnin Director
Florian Fischer Director
Jeanmarie Guenot Director, Executive
Phil Gutry Director
Adi Hoess Director
Mark Mc Dade Director
Eric Moessinger Director
Frank Muhlenbeck Director
Christian Richard Director
Peter Van Vasselaer Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
611 Gateway Blvd. Suite 810
South San Francisco, CA, 94080